941 related articles for article (PubMed ID: 28842577)
21. Nanocatalytic Tumor Therapy by Biomimetic Dual Inorganic Nanozyme-Catalyzed Cascade Reaction.
Gao S; Lin H; Zhang H; Yao H; Chen Y; Shi J
Adv Sci (Weinh); 2019 Feb; 6(3):1801733. PubMed ID: 31168441
[TBL] [Abstract][Full Text] [Related]
22. Combining Cobalt Ferrite Nanozymes with a Natural Enzyme to Reshape the Tumor Microenvironment for Boosted Cascade Enzyme-Like Activities.
Chang J; Qin X; Li S; He F; Gai S; Ding H; Yang P
ACS Appl Mater Interfaces; 2022 Oct; 14(40):45217-45228. PubMed ID: 36190449
[TBL] [Abstract][Full Text] [Related]
23. Degradable Tumor-Responsive Iron-Doped Phosphate-Based Glass Nanozyme for H
Yao Y; Wang Z; Cao Q; Li H; Ge S; Liu J; Sun P; Liu Z; Wu Y; Wang W; Liu J
ACS Appl Mater Interfaces; 2022 Apr; 14(15):17153-17163. PubMed ID: 35394283
[TBL] [Abstract][Full Text] [Related]
24. Size shrinkable drug delivery nanosystems and priming the tumor microenvironment for deep intratumoral penetration of nanoparticles.
Niu Y; Zhu J; Li Y; Shi H; Gong Y; Li R; Huo Q; Ma T; Liu Y
J Control Release; 2018 May; 277():35-47. PubMed ID: 29545106
[TBL] [Abstract][Full Text] [Related]
25. Tumor Microenvironment-Enabled Nanotherapy.
Wang L; Huo M; Chen Y; Shi J
Adv Healthc Mater; 2018 Apr; 7(8):e1701156. PubMed ID: 29283221
[TBL] [Abstract][Full Text] [Related]
26. Advanced biomimetic nanoreactor for specifically killing tumor cells through multi-enzyme cascade.
Liu W; Wu J; Ji X; Ma Y; Liu L; Zong X; Yang H; Dai J; Chen X; Xue W
Theranostics; 2020; 10(14):6245-6260. PubMed ID: 32483451
[TBL] [Abstract][Full Text] [Related]
27. An injectable nanoparticle generator enhances delivery of cancer therapeutics.
Xu R; Zhang G; Mai J; Deng X; Segura-Ibarra V; Wu S; Shen J; Liu H; Hu Z; Chen L; Huang Y; Koay E; Huang Y; Liu J; Ensor JE; Blanco E; Liu X; Ferrari M; Shen H
Nat Biotechnol; 2016 Apr; 34(4):414-8. PubMed ID: 26974511
[TBL] [Abstract][Full Text] [Related]
28. Shrapnel nanoparticles loading docetaxel inhibit metastasis and growth of breast cancer.
Xu P; Meng Q; Sun H; Yin Q; Yu H; Zhang Z; Cao M; Zhang Y; Li Y
Biomaterials; 2015 Sep; 64():10-20. PubMed ID: 26106797
[TBL] [Abstract][Full Text] [Related]
29. Urchin-Shaped Metal Organic/Hydrogen-Bonded Framework Nanocomposite as a Multifunctional Nanoreactor for Catalysis-Enhanced Synergetic Therapy.
Hu C; Wang J; Liu S; Cai L; Zhou Y; Liu X; Wang M; Liu Z; Pang M
ACS Appl Mater Interfaces; 2021 Feb; 13(4):4825-4834. PubMed ID: 33496168
[TBL] [Abstract][Full Text] [Related]
30. Promoting Oxidative Stress in Cancer Starvation Therapy by Site-Specific Startup of Hyaluronic Acid-Enveloped Dual-Catalytic Nanoreactors.
Yao Z; Zhang B; Liang T; Ding J; Min Q; Zhu JJ
ACS Appl Mater Interfaces; 2019 May; 11(21):18995-19005. PubMed ID: 31058483
[TBL] [Abstract][Full Text] [Related]
31. Nanotherapy Targeting the Tumor Microenvironment.
Gong BS; Wang R; Xu HX; Miao MY; Yao ZZ
Curr Cancer Drug Targets; 2019; 19(7):525-533. PubMed ID: 30569855
[TBL] [Abstract][Full Text] [Related]
32. New Strategies in Cancer Nanomedicine.
Tong R; Kohane DS
Annu Rev Pharmacol Toxicol; 2016; 56():41-57. PubMed ID: 26514197
[TBL] [Abstract][Full Text] [Related]
33. Nanocatalysts-augmented Fenton chemical reaction for nanocatalytic tumor therapy.
Qian X; Zhang J; Gu Z; Chen Y
Biomaterials; 2019 Aug; 211():1-13. PubMed ID: 31075521
[TBL] [Abstract][Full Text] [Related]
34. Nanomedicines Targeting the Tumor Microenvironment.
Tong R; Langer R
Cancer J; 2015; 21(4):314-21. PubMed ID: 26222084
[TBL] [Abstract][Full Text] [Related]
35. Captopril improves tumor nanomedicine delivery by increasing tumor blood perfusion and enlarging endothelial gaps in tumor blood vessels.
Zhang B; Jiang T; Tuo Y; Jin K; Luo Z; Shi W; Mei H; Hu Y; Pang Z; Jiang X
Cancer Lett; 2017 Dec; 410():12-19. PubMed ID: 28939029
[TBL] [Abstract][Full Text] [Related]
36. Nano magnetic liposomes-encapsulated parthenolide and glucose oxidase for ultra-efficient synergistic antitumor therapy.
Gao W; Wei S; Li Z; Li L; Zhang X; Li C; Gao D
Nanotechnology; 2020 Aug; 31(35):355104. PubMed ID: 32403097
[TBL] [Abstract][Full Text] [Related]
37. Nanomedicine as a potent strategy in melanoma tumor microenvironment.
Pautu V; Leonetti D; Lepeltier E; Clere N; Passirani C
Pharmacol Res; 2017 Dec; 126():31-53. PubMed ID: 28223185
[TBL] [Abstract][Full Text] [Related]
38. Ruthenium-loaded mesoporous silica as tumor microenvironment-response nano-fenton reactors for precise cancer therapy.
Sun D; Wang Z; Zhang P; Yin C; Wang J; Sun Y; Chen Y; Wang W; Sun B; Fan C
J Nanobiotechnology; 2021 Apr; 19(1):98. PubMed ID: 33827604
[TBL] [Abstract][Full Text] [Related]
39. Targeting tumor microenvironment with PEG-based amphiphilic nanoparticles to overcome chemoresistance.
Chen S; Yang K; Tuguntaev RG; Mozhi A; Zhang J; Wang PC; Liang XJ
Nanomedicine; 2016 Feb; 12(2):269-86. PubMed ID: 26707818
[TBL] [Abstract][Full Text] [Related]
40. Nanomedicines for the treatment of hematological malignancies.
Deshantri AK; Varela Moreira A; Ecker V; Mandhane SN; Schiffelers RM; Buchner M; Fens MHAM
J Control Release; 2018 Oct; 287():194-215. PubMed ID: 30165140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
